Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Ranbaxy gets FDA approval to launch Lipitor's generic version in US

      Ranbaxy Pharmaceuticals Inc., India's largest drugmaker, announced that it has received final approval from the US Food and Drug Administration (USFDA) to launch the most sought-after generic version of Lipitor (called Atorvastatin) in the US market. Lipitor is the blockbuster Cholesterol-lowering drug manufactured by Pfizer Inc.

      Ranbaxy is the first company to get USFDA authorization (first-to-file status) to manufacture generic copy of the patented drug Lipitor. And Ranbaxy has been granted exclusive rights by the FDA to market atorvastatin for 180 days. With this deal, Ranbaxy could fetch millions of dollars in revenue and it is estimated that, during this period, Ranbaxy could generate profit of about $650 million.

      Lipitor is the world's top-selling anti-cholesterol drug that is widely used by millions of people to manage high cholesterol levels over time. This drug lowers bad cholesterol levels and it can raise good cholesterol levels as well. For Americans, FDA's permission to manufacture and market generic drug atorvastatin in the US comes in as an affordable alternative treatment to branded Lipitor in lowering their cholesterol levels.


      Share this Article!

    Back to top^